Filing Details
- Accession Number:
- 0001161697-22-000556
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-22 17:00:16
- Reporting Period:
- 2022-11-18
- Accepted Time:
- 2022-11-22 17:00:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1369568 | Catalyst Pharmaceuticals Inc. | CPRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 929985 | J Patrick Mcenany | 355 Alhambra Circle, Suite 801 Coral Gables FL 33134 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2022-11-18 | 350,000 | $2.24 | 4,252,606 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2022-11-18 | 350,000 | $15.62 | 3,902,606 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2022-11-21 | 150,000 | $2.24 | 4,052,606 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2022-11-21 | 150,000 | $15.33 | 3,902,606 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to purchase common stock | Disposition | 2022-11-18 | 350,000 | $0.00 | 350,000 | $2.24 |
| Common Stock | Options to purchase common stock | Disposition | 2022-11-21 | 150,000 | $0.00 | 150,000 | $2.24 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,015,834 | 2025-12-19 | No | 4 | M | Direct | |
| 2,865,834 | 2025-12-19 | No | 4 | M | Direct |
Footnotes
- Shares were sold for personal reasons. Shares were not sold as a result of any disagreement with the Company and Mr. McEnany remains a director and an officer of the Company.
- Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.50 to $16.06 per share.
- Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.19 to $15.55 per share.
- Options vested in three equal tranches on December 19, 2019, 2020 and 2021.
Billionaire Hedge Funds
